Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 728

    1.

    Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.

    Jaleel A, Halvatsiotis P, Williamson B, Juhasz P, Martin S, Nair KS.

    Diabetes Care. 2005 Mar;28(3):645-52.PMID: 15735202 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Transcapillary filtration of plasma proteins in patients with diabetes type II microangiopathy complications]

    Muszyńska-Lachota I.

    Ann Acad Med Stetin. 2002;48:255-69. Polish. PMID: 14601482 [PubMed - indexed for MEDLINE]Related articles

    3.

    A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes.

    Stork AD, Erkelens DW, Veneman TF.

    Diabetes Res Clin Pract. 2006 Jun;72(3):251-7. Epub 2005 Dec 1.PMID: 16325299 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.

    Avellone G, di Garbo V, Cordova R, Rotolo G, Raneli G, de Simone R, Bompiani G.

    Metabolism. 1997 Aug;46(8):930-4.PMID: 9258277 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of exogenous insulin on protein metabolism with differing nonprotein energy intakes in Type 2 diabetes mellitus.

    Gougeon R, Marliss EB, Jones PJ, Pencharz PB, Morais JA.

    Int J Obes Relat Metab Disord. 1998 Mar;22(3):250-61.PMID: 9539194 [PubMed - indexed for MEDLINE]Related articles

    6.

    Long-term glycemic control relates to mortality in type II diabetes.

    Andersson DK, Svärdsudd K.

    Diabetes Care. 1995 Dec;18(12):1534-43.PMID: 8722048 [PubMed - indexed for MEDLINE]Related articles

    7.

    Is type 2 diabetes a different disease in obese and nonobese patients?

    Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, Odetti P.

    Diabetes Care. 1998 Oct;21(10):1680-5.PMID: 9773730 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

    Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

    Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.PMID: 17919531 [PubMed - indexed for MEDLINE]Related articles

    9.

    Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes.

    Halvatsiotis P, Short KR, Bigelow M, Nair KS.

    Diabetes. 2002 Aug;51(8):2395-404.PMID: 12145150 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes]

    Li YB, Zhu HL, Yao B, Huang ZM, Ou XZ, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):602-5. Chinese. PMID: 15949356 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.

    Gougeon R.

    Obes Res. 2001 Apr;9(4):241-50.PMID: 11331427 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

    Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS.

    Diabetes. 2002 Jun;51(6):1913-20.PMID: 12031981 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

    Ryan EA, Imes S, Wallace C.

    Diabetes Care. 2004 May;27(5):1028-32.PMID: 15111515 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.

    Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, van Hinsbergh VW.

    Diabetes. 1999 Dec;48(12):2446-53.PMID: 10580435 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.

    Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

    J Investig Med. 2006 Jan;54(1):20-31.PMID: 16409887 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.

    Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y.

    Metabolism. 2002 Apr;51(4):471-6.PMID: 11912556 [PubMed - indexed for MEDLINE]Related articles

    19.

    Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?

    Gungor N, Bacha F, Saad R, Janosky J, Arslanian S.

    Diabetes Care. 2005 Mar;28(3):638-44.PMID: 15735201 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data